Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Burlington › NPI 1275788416
Physician

Grove Park Pediatrics

Grove Park Pediatrics was paid $8.51M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.

33Billing provider infoGROVE PARK PEDIATRICS
BURLINGTON, NC 27215
33aNPI1275788416assigned 12/01/2008
33bProvider typePediatrics Physician
28Total paid$8.51M
24GClaims459,996
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in North Carolina

Rank by total paid#43 of 433
Median peer was paid$942K
This provider vs. median9.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201838,484$1.18M
201940,478$1.49M
202030,745$1.20M
202152,705$1.16M
202285,455$1.09M
202387,395$1.00M
2024incomplete124,734$1.41M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 28% 37,170 30,465 $2.42M
99199 Unlisted special service, procedure or report 16% 258,610 135,128 $1.34M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15% 12,987 11,555 $1.27M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 7.4% 6,683 6,529 $631K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 6.5% 5,344 5,165 $551K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 6.3% 5,896 5,737 $539K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.8% 3,745 3,576 $326K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 3.4% 15,086 14,629 $285K
90472 Immunization administration, each additional vaccine (list separately) 1.9% 6,556 6,395 $166K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.7% 2,974 2,777 $145K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.7% 7,871 4,954 $142K
D0145 Oral evaluation for a patient under three years of age 1.6% 4,131 4,016 $139K
65 more codes
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.1% 6,570 $90K
D1206 Topical application of fluoride varnish <1% 4,130 $61K
92567 <1% 3,451 $47K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 1,524 $44K
90651 <1% 1,913 $43K
99058 <1% 1,879 $29K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 258 $27K
90474 <1% 1,356 $26K
99381 <1% 281 $26K
90734 <1% 1,386 $23K
94664 <1% 1,939 $21K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 3,133 $16K
92551 <1% 14,407 $16K
87807 <1% 1,161 $15K
99050 <1% 565 $13K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,059 $11K
99173 <1% 14,480 $10K
83655 <1% 543 $7K
90480 <1% 120 $5K
90473 <1% 286 $5K
90686 <1% 6,554 $4K
99204 Doctor's office visit, new patient (more involved) <1% 26 $4K
90715 <1% 804 $4K
0071A <1% 37 $2K
96127 <1% 477 $2K
0072A <1% 27 $2K
81002 <1% 433 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 55 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 16 $571.95
90672 <1% 747 $466.86
90619 <1% 504 $304.83
90633 <1% 1,803 $297.88
99051 <1% 19 $264.80
90688 <1% 72 $232.05
85018 <1% 85 $219.83
90697 <1% 469 $150.74
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 13 $26.00
90707 0% 478 $0.00
90681 0% 1,237 $0.00
G9920 Screening performed and negative 0% 119 $0.00
90710 0% 443 $0.00
1160F 0% 2,103 $0.00
90700 0% 430 $0.00
91322 0% 30 $0.00
90670 0% 2,399 $0.00
90671 0% 502 $0.00
3078F 0% 1,455 $0.00
91320 0% 18 $0.00
91321 0% 17 $0.00
90687 0% 58 $0.00
90685 0% 52 $0.00
90716 0% 520 $0.00
3074F 0% 1,508 $0.00
90723 0% 1,743 $0.00
90677 0% 128 $0.00
90696 0% 429 $0.00
3008F 0% 1,682 $0.00
90647 0% 1,810 $0.00
3079F 0% 41 $0.00
2001F 0% 2,440 $0.00
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 0% 13 $0.00
90656 0% 603 $0.00
91319 0% 16 $0.00
91307 0% 69 $0.00
91318 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGOLDAR, MARGARITA (OWNER)